In vitro inhibitory effects of 16-methyl-substituted steroids on 5 alpha-reductase in rat and human prostates.
The inhibitory effects (IC50) of 16-methyl steroids on 5 alpha-reductase were studied. The in vitro experiments were carried out with homogenates of rat and human prostates. The investigated 16-methyl steroids were found to be weak inhibitors. In comparison with the known 5 alpha-reductase inhibitor 4-MA (17 beta-N, N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one), the relative IC50 values of the studied compounds are 4.7 times or more greater than 4-MA in human prostate and 23.5 times or more greater than 4-MA in rat prostate. The IC50 values increase in the sequence 16 alpha-, 16 beta- and 16,16-dimethyl derivatives. In human prostate homogenates IC50 varies between 0.6 and 120, while in rat it ranges from 1.6 to 1000 microM. This shows that the enzyme of the human prostate is more sensitive than that of the rat prostate to the methyl-substituted compounds.
Faredin
I
I
First Department of Medicine, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Tóth
I
I
Wölfling
J
J
Schneider
G
G
Meskó
E
E
D000818:Animals; D042944:Cholestenone 5 alpha-Reductase; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011467:Prostate / Q000187:drug effects* / Q000201:enzymology*; D011470:Prostatic Hyperplasia / Q000201:enzymology; D051381:Rats; D012680:Sensitivity and Specificity; D013256:Steroids / Q000138:chemical synthesis* / Q000494:pharmacology*
D013256:Steroids; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase